Skip to content
10-K

Annual Report

Guardian Pharmacy Services, Inc. GRDN

0001193125-26-102172

← back to feed
Filed
Mar 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Capex FY 2025 · Dec 31, 2025 $13.42M
Capex FY 2025 · Dec 31, 2024 $14.71M
Operating Cash Flow FY 2025 · Dec 31, 2025 $100.26M
Operating Cash Flow FY 2025 · Dec 31, 2024 $57.96M
Cash And Equivalents FY 2025 · Dec 31, 2025 $65.62M
Cash And Equivalents FY 2025 · Dec 31, 2024 $4.66M
Stockholders Equity FY 2025 · Dec 31, 2025 $217.92M
Stockholders Equity FY 2025 · Dec 31, 2024 $149.98M
Stockholders Equity FY 2025 · Dec 31, 2023 $59.86M
Current Liabilities FY 2025 · Dec 31, 2025 $160.7M
Current Liabilities FY 2025 · Dec 31, 2024 $144.12M
Total Liabilities FY 2025 · Dec 31, 2025 $194.73M
Total Liabilities FY 2025 · Dec 31, 2024 $170.83M
Current Assets FY 2025 · Dec 31, 2025 $221.63M
Current Assets FY 2025 · Dec 31, 2024 $151.99M
Total Assets FY 2025 · Dec 31, 2025 $412.66M
Total Assets FY 2025 · Dec 31, 2024 $320.81M
Sga Expense FY 2025 · Dec 31, 2025 $220.02M
Sga Expense FY 2025 · Dec 31, 2024 $307.29M
Net Income FY 2025 · Dec 31, 2025 $49.22M
Net Income FY 2025 · Dec 31, 2024 −$110.05M
Operating Income FY 2025 · Dec 31, 2025 $72.7M
Operating Income FY 2025 · Dec 31, 2024 −$62.92M
Gross Profit FY 2025 · Dec 31, 2025 $292.72M
Gross Profit FY 2025 · Dec 31, 2024 $244.37M
Cost Of Revenue FY 2025 · Dec 31, 2025 $1.16B
Cost Of Revenue FY 2025 · Dec 31, 2024 $984.04M
Revenue FY 2025 · Dec 31, 2025 $1.45B
Revenue FY 2025 · Dec 31, 2024 $1.23B